Matt Arnold Email & Phone Number

Bethesda, MD, US

Washington, DC, US

Adjunct instructor of management strategy and cell & gene therapy

San Francisco, CA, US

Our mission is to improve human health and performance by creating clinically-proven, non-invasive neurostimulation products.

Targeted Protein Degradation

Cambridge, Massachusetts, US

• Led the Supply Chain, Quality Assurance, and Program and Portfolio Management functions.
• Implemented supply chains for a regional CMO network supporting global ex vivo autologous gene therapy clinical trials.
• Built the Quality Assurance organization and implementation roadmap for a comprehensive, phase-appropriate Quality Management System.

Management consultant and advisor for strategy and business operations, including developing a growth strategy for a rapidly expanding boutique research firm (CRO) and operational effectiveness for a medical device company’s US business.

Cambridge, Cambridgeshire, GB

• Led the global delivery of commercial and clinical supply for the oncology portfolio (>$5B revenue, ~20 pipeline programs). Managed global teams based in the US, UK, and Sweden with responsibility for supply chain.
• Delivered ~80 market launches of five brands, on time every time.
• Executed three new product launches in the US within 24 hours of approval (Imfinzi®, Lynparza®, and Calquence®). Launched Tagrisso® in China in 23 days, one third of the typical timeframe.
• Exceeded supply service level targets, achieving 99.6% stock availability of 11 brands across >80 markets globally (vs. target of 99%).
• Ensured flawless supply of Lynparza® during rolling market launches and multiple, simultaneous supply chain changes (capsule to tablet formulation, qualification of 2nd source for API, parallel formulation site tech.
• In collaboration with manufacturing, engineering, technical development, and finance colleagues, developed $200M Board proposal for new Zoladex® formulation plant.

Cambridge, Cambridgeshire, GB

• Directed a global organization of 140 staff and 600 contractors across five sites in the US, UK, Sweden, and India ($180M budget). Managed core business operations essential to all functions and sites. Oversaw project.
• Built a global Project Management organization to enhance planning, execution, and tracking capabilities for the portfolio of IMED drug development projects. From 2013 to 2016, key R&D productivity metrics improved and.
• Reduced overall site facilities costs by $71M (33%) 2013-2016 while increasing both vibrancy and service levels. Transformed an underutilized research site in Boston by developing and implementing a “BioHub” model..
• Achieved the highest overall scores of any IMED function in AstraZeneca’s biennial climate survey, reflecting high levels of staff motivation, engagement, and belief in organizational strategy and direction.
• Planned and facilitated biannual meetings of the Board Science Committee to assess the quality, competitiveness, and integrity of R&D activities. Organized multiple ad hoc Science Committee meetings to review specific.

Gaithersburg, Maryland, US

• Aligned company strategy, time and focus of the President, and the activities of MedImmune’s executive team to orchestrate an agenda for leadership across the organization. Oversaw business governance forums and.
• Every financial target and enterprise scorecard objective was met or exceeded.
• Key industry alliances were established and executed (co-development of five molecules with Amgen, manufacturing capacity sharing with Merck, and China JV with WuXi).

Thousand Oaks, CA, US

• Selected by SVP of Quality to build and lead organization of 20 risk management professionals across a global manufacturing and distribution network. Led major operational excellence initiative to analyze and mitigate.
• Developed and implemented mitigation strategies for key risks from geographic concentration of operations, single sources of raw materials and manufacturing, and distressed suppliers.
• Established a business continuity plan for North American distribution operations, providing risk mitigation of $11.5 billion annual revenues.

Thousand Oaks, CA, US

• Expatriate assignment reporting to the SVP, International Chief Medical Officer. Integral to all operational aspects of building then managing an integrated multinational organization of 900 medical and clinical.
• Led cross-functional analysis of the size, structure, and business processes of regional headquarter and country affiliate organizations. Developed and implemented restructuring plans that reduced cumulative operating.
• Developed resource deployment plans for market expansion and product launches in new therapeutic areas.

Thousand Oaks, CA, US

Drove the development and implementation of a global strategic plan for the largest oncology program in Amgen’s pipeline ($400M budget, 8,000 patients, six Phase III, and five Phase II studies across indications). Orchestrated execution of product development strategy across clinical development, commercial, operations, regulatory, medical affairs, and.

Thousand Oaks, CA, US

Built and led a 14-person organization to manage business development operations and external research alliances.

Thousand Oaks, CA, US

Co-led team in the design and execution of an erythropoiesis-stimulating agents (ESA) medical usage evaluation involving 1,000 patients from approximately 30 sites and sources. Drove preparation of multiple submissions to the Center for Medicare and Medicaid Services (CMS) analyzing dosing and outcomes of Aranesp® and Procrit® patients. Senior project.

Thousand Oaks, CA, US

Selected by SVP, HR to lead cross-functional team developing and executing a comprehensive plan for staff selection and integration during $13B acquisition of Immunex. Utilized Six Sigma methodology, led a staffing process improvement project resulting in annualized savings of $5-10M. Program Manager for leadership development and talent management programs.

Camarillo, CA, US

Washington, DC, US

• Ranked in the top 10% of faculty by student surveys.
• Assistant Coach and Operations Officer for varsity offshore sailing team

Washington, DC, US

• Commanding officer of a special operations ship with a crew of 30 for numerous counter-narcotics, Navy SEAL, and Army Special Forces missions. The most junior Surface Warfare commanding officer in the US Navy during.
• Seized ~$25M worth of controlled substances during bilateral mission with the Colombian Navy.
• Earned Navy Battle Efficiency and Golden Trident unit awards for outstanding material condition, training proficiency, combat readiness, and working environment for crew.

Washington, DC, US

• Led a division of 40 engineers accountable for the operation, maintenance and repair of propulsion and auxiliary engineering systems.
• Overall coordinator for Operational Propulsion Plant Examination (OPPE), a comprehensive engineering inspection required to certify ship for operations. Completed the 3-day inspection in 36 hours (a Pacific Fleet.
• Project manager for over 50 complex ship alterations during 14 month, $100 million overhaul.

Bs

Ms, Biochemistry And Molecular Biology

Mba, General Management